DrugPatentWatch Database Preview
Ptc Therap Company Profile
What is the competitive landscape for PTC THERAP, and what generic and branded alternatives to PTC THERAP drugs are available?
PTC THERAP has two approved drugs.
Summary for Ptc Therap
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Ptc Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-003 | Feb 9, 2017 | RX | Yes | No | Start Trial | Start Trial | |||||
| Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-002 | Feb 9, 2017 | RX | Yes | No | Start Trial | Start Trial | |||||
| Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-001 | Feb 9, 2017 | RX | Yes | No | Start Trial | Start Trial | |||||
| Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-002 | Feb 9, 2017 | RX | Yes | No | Start Trial | Start Trial | |||||
| Ptc Therap | EMFLAZA | deflazacort | SUSPENSION;ORAL | 208685-001 | Feb 9, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Ptc Therap | EMFLAZA | deflazacort | SUSPENSION;ORAL | 208685-001 | Feb 9, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Ptc Therap | EMFLAZA | deflazacort | TABLET;ORAL | 208684-004 | Feb 9, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
